146 related articles for article (PubMed ID: 24291224)
1. Discordance of IGF-1 and GH stimulation testing for altered GH secretion in obesity.
Stanley TL; Feldpausch MN; Murphy CA; Grinspoon SK; Makimura H
Growth Horm IGF Res; 2014 Feb; 24(1):10-5. PubMed ID: 24291224
[TBL] [Abstract][Full Text] [Related]
2. The relationship between reduced testosterone, stimulated growth hormone secretion and increased carotid intima-media thickness in obese men.
Makimura H; Stanley TL; Sun N; Connelly JM; Hemphill LC; Grinspoon SK
Clin Endocrinol (Oxf); 2010 Nov; 73(5):622-9. PubMed ID: 20681993
[TBL] [Abstract][Full Text] [Related]
3. Reduced growth hormone secretion is associated with increased carotid intima-media thickness in obesity.
Makimura H; Stanley T; Mun D; Chen C; Wei J; Connelly JM; Hemphill LC; Grinspoon SK
J Clin Endocrinol Metab; 2009 Dec; 94(12):5131-8. PubMed ID: 19837914
[TBL] [Abstract][Full Text] [Related]
4. Androgens may mediate a relative preservation of IGF-I levels in overweight and obese women despite reduced growth hormone secretion.
Utz AL; Yamamoto A; Sluss P; Breu J; Miller KK
J Clin Endocrinol Metab; 2008 Oct; 93(10):4033-40. PubMed ID: 18647804
[TBL] [Abstract][Full Text] [Related]
5. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status.
Savastano S; Di Somma C; Colao A; Barrea L; Orio F; Finelli C; Pasanisi F; Contaldo F; Tarantino G
Growth Horm IGF Res; 2015 Feb; 25(1):28-33. PubMed ID: 25466907
[TBL] [Abstract][Full Text] [Related]
6. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
Alvarez P; Isidro L; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
[TBL] [Abstract][Full Text] [Related]
7. The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis.
Colao A; Di Somma C; Spiezia S; Rota F; Pivonello R; Savastano S; Lombardi G
J Clin Endocrinol Metab; 2006 Jun; 91(6):2191-200. PubMed ID: 16537686
[TBL] [Abstract][Full Text] [Related]
8. Influence of chronic Naltrexone treatment on growth hormone and insulin secretion in obese subjects.
De Marinis L; Mancini A; Valle D; Bianchi A; De Luca AM; Fulghesu AM; Villa P; Mancuso S; Lanzone A
Int J Obes Relat Metab Disord; 1997 Nov; 21(11):1076-81. PubMed ID: 9368834
[TBL] [Abstract][Full Text] [Related]
9. Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test.
Maccario M; Gauna C; Procopio M; Di Vito L; Rossetto R; Oleandri SE; Grottoli S; Ganzaroli C; Aimaretti G; Ghigo E
J Endocrinol Invest; 1999 Jun; 22(6):424-9. PubMed ID: 10435851
[TBL] [Abstract][Full Text] [Related]
10. Impairment of GH secretion in adults with primary empty sella.
Gasperi M; Aimaretti G; Cecconi E; Colao A; Di Somma C; Cannavò S; Baffoni C; Cosottini M; Curtò L; Trimarchi F; Lombardi G; Grasso L; Ghigo E; Martino E
J Endocrinol Invest; 2002 Apr; 25(4):329-33. PubMed ID: 12030603
[TBL] [Abstract][Full Text] [Related]
11. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone in obesity.
Scacchi M; Pincelli AI; Cavagnini F
Int J Obes Relat Metab Disord; 1999 Mar; 23(3):260-71. PubMed ID: 10193871
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
Gleeson HK; Lissett CA; Shalet SM
J Clin Endocrinol Metab; 2005 Feb; 90(2):1061-7. PubMed ID: 15522943
[TBL] [Abstract][Full Text] [Related]
14. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa.
Gianotti L; Pincelli AI; Scacchi M; Rolla M; Bellitti D; Arvat E; Lanfranco F; Torsello A; Ghigo E; Cavagnini F; Müller EE
J Clin Endocrinol Metab; 2000 Aug; 85(8):2805-9. PubMed ID: 10946886
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial.
Makimura H; Feldpausch MN; Rope AM; Hemphill LC; Torriani M; Lee H; Grinspoon SK
J Clin Endocrinol Metab; 2012 Dec; 97(12):4769-79. PubMed ID: 23015655
[TBL] [Abstract][Full Text] [Related]
17. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.
Iranmanesh A; South S; Liem AY; Clemmons D; Thorner MO; Weltman A; Veldhuis JD
Eur J Endocrinol; 1998 Jul; 139(1):59-71. PubMed ID: 9703380
[TBL] [Abstract][Full Text] [Related]
18. Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation.
Bondanelli M; Ambrosio MR; Margutti A; Boldrini P; Basaglia N; Franceschetti P; Zatelli MC; Degli Uberti EC
Metabolism; 2002 Oct; 51(10):1363-9. PubMed ID: 12370860
[TBL] [Abstract][Full Text] [Related]
19. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations.
Bernardi F; Petraglia F; Seppala M; Spinetti A; Bertolini S; Ferdeghini M; Genazzani AR
Hum Reprod; 1998 Feb; 13(2):279-84. PubMed ID: 9557822
[TBL] [Abstract][Full Text] [Related]
20. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index.
Corneli G; Di Somma C; Baldelli R; Rovere S; Gasco V; Croce CG; Grottoli S; Maccario M; Colao A; Lombardi G; Ghigo E; Camanni F; Aimaretti G
Eur J Endocrinol; 2005 Aug; 153(2):257-64. PubMed ID: 16061832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
